Charles Schwab Investment Management Inc. Acquires 25,004 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Charles Schwab Investment Management Inc. boosted its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 2.4% in the 4th quarter, Holdings Channel.com reports. The firm owned 1,086,811 shares of the company’s stock after purchasing an additional 25,004 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in HealthEquity were worth $104,280,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently added to or reduced their stakes in the business. Wasatch Advisors LP raised its holdings in HealthEquity by 6.6% in the 3rd quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company’s stock valued at $635,065,000 after acquiring an additional 483,269 shares in the last quarter. State Street Corp raised its holdings in HealthEquity by 0.8% in the 3rd quarter. State Street Corp now owns 3,131,900 shares of the company’s stock valued at $256,346,000 after acquiring an additional 23,613 shares in the last quarter. Geode Capital Management LLC raised its holdings in HealthEquity by 0.7% in the 3rd quarter. Geode Capital Management LLC now owns 2,078,977 shares of the company’s stock valued at $170,197,000 after acquiring an additional 15,145 shares in the last quarter. Franklin Resources Inc. raised its holdings in HealthEquity by 0.7% in the 3rd quarter. Franklin Resources Inc. now owns 1,640,215 shares of the company’s stock valued at $139,369,000 after acquiring an additional 11,659 shares in the last quarter. Finally, Loomis Sayles & Co. L P raised its holdings in HealthEquity by 2.2% in the 3rd quarter. Loomis Sayles & Co. L P now owns 1,126,645 shares of the company’s stock valued at $92,216,000 after acquiring an additional 24,665 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the transaction, the director now directly owns 78,219 shares in the company, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Stuart B. Parker sold 25,000 shares of the firm’s stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the completion of the transaction, the director now owns 19,061 shares in the company, valued at $1,843,579.92. This represents a 56.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 2.20% of the company’s stock.

HealthEquity Stock Down 0.7 %

Shares of HQY opened at $100.58 on Monday. The firm has a market capitalization of $8.72 billion, a price-to-earnings ratio of 92.28, a PEG ratio of 1.60 and a beta of 0.62. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The business’s fifty day moving average price is $105.80 and its two-hundred day moving average price is $94.66. HealthEquity, Inc. has a 52 week low of $65.01 and a 52 week high of $115.59.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Monday, December 9th. The company reported $0.59 EPS for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period in the prior year, the business earned $0.40 earnings per share. On average, analysts predict that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on HQY. Royal Bank of Canada increased their target price on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Tuesday, December 10th. Raymond James increased their target price on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a report on Tuesday, February 25th. Bank of America increased their target price on HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a report on Wednesday, November 13th. Barrington Research increased their target price on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a report on Monday, December 2nd. Finally, Wells Fargo & Company increased their target price on HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a report on Wednesday, February 26th. One investment analyst has rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $113.54.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.